{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:46:54Z","timestamp":1773215214837,"version":"3.50.1"},"reference-count":22,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T00:00:00Z","timestamp":1258588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:sec><jats:label\/><jats:p> <jats:italic>Aliment Pharmacol Ther<\/jats:italic>\u2002<jats:bold>31<\/jats:bold>, 523\u2013533<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Common reasons for elective screening and surveillance colonoscopy, at predetermined intervals, are family or personal history of colorectal cancer (CRC) or advanced adenoma (AAP). Quantified, human haemoglobin (Hb)\u2010specific, immunochemical faecal occult blood tests (I\u2010FOBT) detect bleeding.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To determine I\u2010FOBT sensitivity for CRC or AAP before elective colonoscopy in patients at high\u2010risk of cancer or advanced adenoma.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Prospective double\u2010blind study of 1000 ambulatory asymptomatic high\u2010risk patients (555 family history of CRC, 445 surveillance for past neoplasm), who prepared three I\u2010FOBTs before elective colonoscopy. I\u2010FOBTs quantified as ngHb\/mL of buffer by OC\u2010MICRO instrument and results \u226550\u2003ngHb\/mL considered positive.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> At colonoscopy, eight patients had CRC, 64 others had AAP. Sensitivity for CRC and\/or AAP was the highest, 65.3% (95% CI 54.3, 76.3), when any of the three I\u2010FOBTs was \u226550\u2003ngHb (15.4%), with specificity of 87.5% (95% CI 86.4, 90.5) identifying all CRCs and 62% of AAPs.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> All cancers or an AAP were detected every third I\u2010FOBT\u2010positive colonoscopy (47\/154), so colonoscopy was potentially not needed at this time in 84.6% (846 patients). I\u2010FOBT screening might provide effective supervision of high\u2010risk patients, delaying unnecessary elective colonoscopies. This favourable evaluation needs confirmation and cost\u2013benefit study by risk\u2010group.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2009.04202.x","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T17:15:23Z","timestamp":1258650923000},"page":"523-533","source":"Crossref","is-referenced-by-count":24,"title":["Can patients at high risk for significant colorectal neoplasms and having normal quantitative faecal occult blood test postpone elective colonoscopy?"],"prefix":"10.1111","volume":"31","author":[{"given":"R.","family":"HAZAZI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"ROZEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"LESHNO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"LEVI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"SAMUEL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"WAKED","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"VILKIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"MAOZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"BIRKENFELD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"NIV","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,1,12]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.56.3.143"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.104"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38606.794560.EB"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03898.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800801114"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2005.06.037"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-5-376"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-4-200702200-00003"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03946.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.043786"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03152.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.00231.x"},{"key":"e_1_2_6_14_2","first-page":"MT27","article-title":"Evaluation of a desk top instrument for the automated development and immunochemical quantification of fecal occult blood","volume":"12","author":"Rozen P","year":"2006","journal-title":"Med Sci Monit"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.14"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(03)00136-8"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(04)02765-8"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.05.012"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.07.012"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.10.027"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-9-200611070-00007"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/jms.9.3.99"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200007203430302"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2009.04202.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2009.04202.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T11:25:56Z","timestamp":1698751556000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2009.04202.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,12]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1365-2036.2009.04202.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04202.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,12]]}}}